189 related articles for article (PubMed ID: 7742585)
1. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.
Pageaux GP; Perrigault PF; Fabre JM; Portales P; Souche B; Dereure O; Eliaou JF; Larrey D; Domergue J; Michel H
Clin Transplant; 1995 Feb; 9(1):65-9. PubMed ID: 7742585
[TBL] [Abstract][Full Text] [Related]
2. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
3. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.
Pollack MS; Speeg KV; Callander NS; Freytes CO; Espinoza AA; Esterl RM; Abrahamian GA; Washburn WK; Halff GA
Hum Immunol; 2005 Jan; 66(1):28-31. PubMed ID: 15620459
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
6. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
7. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
Nakai K; Mineishi S; Kami M; Saito T; Hori A; Kojima R; Imataki O; Hamaki T; Yoshihara S; Ohnishi M; Kim SW; Ando T; Fumitoh A; Kanda Y; Makimoto A; Tanosaki R; Kanai S; Heike Y; Ohnishi T; Kawano Y; Wakasugi H; Takaue Y
Transplantation; 2003 Jun; 75(12):2135-43. PubMed ID: 12829926
[TBL] [Abstract][Full Text] [Related]
8. Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Wiesmann A; Bader P; Bamberg M; Faul C; Kanz L; Einsele H
Bone Marrow Transplant; 2003 Sep; 32(5):511-3. PubMed ID: 12942098
[TBL] [Abstract][Full Text] [Related]
9. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease following living donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
[TBL] [Abstract][Full Text] [Related]
11. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
Mawad R; Hsieh A; Damon L
Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
[TBL] [Abstract][Full Text] [Related]
13. Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis.
Worel N; Bojic A; Binder M; Jaksch P; Mitterbauer G; Streubel B; Thalhammer F; Staudinger T; Laczika KF; Locker GJ
Transpl Int; 2008 Nov; 21(11):1098-101. PubMed ID: 18764830
[TBL] [Abstract][Full Text] [Related]
14. Graft-vs-host disease after solid organ transplant.
Gulbahce HE; Brown CA; Wick M; Segall M; Jessurun J
Am J Clin Pathol; 2003 Apr; 119(4):568-73. PubMed ID: 12710129
[TBL] [Abstract][Full Text] [Related]
15. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
16. Chimerism and tolerance in a recipient of a deceased-donor liver transplant.
Alexander SI; Smith N; Hu M; Verran D; Shun A; Dorney S; Smith A; Webster B; Shaw PJ; Lammi A; Stormon MO
N Engl J Med; 2008 Jan; 358(4):369-74. PubMed ID: 18216357
[TBL] [Abstract][Full Text] [Related]
17. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor.
Hajeer AH; Issa S; Alaskar A; Abdullah K; Awad M; Tbakhi A; Alabdulkareem A
Transplant Proc; 2005 Dec; 37(10):4386-8. PubMed ID: 16387127
[TBL] [Abstract][Full Text] [Related]
19. Late onset of severe graft-versus-host disease following liver transplantation.
Sun B; Zhao C; Xia Y; Li G; Cheng F; Li J; Zhang F; Wang X
Transpl Immunol; 2006 Nov; 16(3-4):250-3. PubMed ID: 17138062
[TBL] [Abstract][Full Text] [Related]
20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
